Skip to Main Content

Author Details

Charles G Mullighan
St Jude Children's Research Hospital
1996
353
97
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37890117Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.J Clin Oncol2024
38058200CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.Haematologica2024
36352514Characterisation of children and adolescents with acute lymphoblastic leukaemia who presented without peripheral blood blasts at diagnosis.Br J Haematol2023
37961674Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.Res Sq2023
37543655Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia.Leukemia2023
37986997Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.medRxiv2023
37575398Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells.Bio Protoc2023
37820294Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL.J Clin Oncol2023
37770423Defining the condensate landscape of fusion oncoproteins.Nat Commun2023
37729596Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL.J Clin Oncol2023
37725576Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.Clin Cancer Res2023
37060567Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.Cell Rep2023
37216686The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.Blood2023
37453060Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia.Cell Rep2023
37076694Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia.Leukemia2023
37172201The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia.Blood2023
37001051Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.Blood2023
37196217Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in <i>ABL</i> Class Rearrangements.JCO Precis Oncol2023
36877915The International Consensus Classification of acute leukemias of ambiguous lineage.Blood2023
36877196Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.Am J Hematol2023
36604538Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response.Nat Med2023
36422706International Consensus Classification of acute lymphoblastic leukemia/lymphoma.Virchows Arch2023
36824825Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures.bioRxiv2023
36658389Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.Leukemia2023
36309560Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.Leukemia2023
35926109Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights.Blood2023
34256129Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.Semin Cancer Biol2022
35442720Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing.JCO Precis Oncol2022
35351983RNAseqCNV: analysis of large-scale copy number variations from RNA-seq data.Leukemia2022
35767897International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.Blood2022
35671062Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.Blood Adv2022
35421216BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.Blood2022
35590059Acute lymphoblastic leukemia displays a distinct highly methylated genome.Nat Cancer2022
35513723CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.Nat Genet2022
36480778Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.JCO Precis Oncol2022
36518527A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1.NAR Cancer2022
36138187NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.Nat Immunol2022
36130297Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.Blood2022
36301633KMT2A-rearranged leukemia: the shapeshifter.Blood2022
36050548The genomic landscape of pediatric acute lymphoblastic leukemia.Nat Genet2022
36316474Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation.Nat Immunol2022
36077796Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia.Cancers (Basel)2022
35914226Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies.Blood2022
35156727The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation.EMBO J2022
35247902ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.Blood Cancer Discov2022
35177627CytofIn enables integrated analysis of public mass cytometry datasets using generalized anchors.Nat Commun2022
35176137Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.Blood Cancer Discov2022
35115686Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.Nat Genet2022
34903620Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.Cancer Discov2022
35300081Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACs.ACS Med Chem Lett2022
  • 1 - 50 of 353

Recommended Authors

Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 11
Yanara Marincevic-Zuniga
Uppsala University
Career Start Year 2012
Number of shared co-authors 2
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 16
Xinjie Xu
Mayo Clinic
Career Start Year 2011
Number of shared co-authors 13
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 6
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 3
Jessica Nordlund
Uppsala University
Career Start Year 2009
Number of shared co-authors 6
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 14
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 7
Camille Lobry
INSERM U1170, Universite Paris Saclay
Career Start Year 2007
Number of shared co-authors 13
Pascal St-Onge
CHU Sainte-Justine Research Center
Career Start Year 2007
Number of shared co-authors 4
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 31
Don??t Alp??r
Semmelweis University
Career Start Year 2006
Number of shared co-authors 1
Emmanuelle Clappier
Saint-Louis Hospital
Career Start Year 2005
Number of shared co-authors 11
Michael Gombert
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2004
Number of shared co-authors 4
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2004
Number of shared co-authors 26
Christopher C Porter
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 20
Alexander Kohlmann
Oncology R&D
Career Start Year 2002
Number of shared co-authors 10
Gudrun G??hring
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 14
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 6
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 24
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 14
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 33
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 23
Mar??a D Odero
University of Navarra
Career Start Year 1994
Number of shared co-authors 5
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 30
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 29
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 21
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 23

Collaborators

Kathryn G Roberts
St Jude Children's Research Hospital
Co-authored papers 77
Stephen P Hunger
Children's Hospital of Philadelphia
Co-authored papers 74
Mignon L Loh
University of Washington
Co-authored papers 68
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 61
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Co-authored papers 56
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 46
Meenakshi Devidas
St Jude Children's Research Hospital
Co-authored papers 44
William E Evans
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers 36
Cheng Cheng
St. Jude Children's Research Hospital
Co-authored papers 34
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 30
Chunxu Qu
Co-authored papers 27
Stanley Pounds
St. Jude Children's Research Hospital.
Co-authored papers 26
Michael Rusch
St Jude Children's Research Hospital
Co-authored papers 26
John Easton
St Jude Children's Research Hospital
Co-authored papers 26
Sima Jeha
St. Jude Children's Research Hospital
Co-authored papers 24
Malcolm A Smith
National Cancer Institute
Co-authored papers 20
Michael N Edmonson
St. Jude Children's Research Hospital
Co-authored papers 18
Elaine R Mardis
The Ohio State University
Co-authored papers 18
Xiang Chen
St. Jude Children's Research Hospital
Co-authored papers 17
Daniela S Gerhard
National Cancer Institute
Co-authored papers 16
Yongjin Li
Mayo Clinic
Co-authored papers 14
Richard K Wilson
The Ohio State University
Co-authored papers 14
Kristine R Crews
St. Jude Children's Research Hospital
Co-authored papers 13
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Jeffery M Klco
St. Jude Children's Research Hospital
Co-authored papers 13
Kim E Nichols
St. Jude Children's Research Hospital
Co-authored papers 13
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 12
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 12
Xiaotu Ma
St. Jude Children's Research Hospital
Co-authored papers 12
Anthony V Moorman
Translational and Clinical Research Institute, Newcastle University
Co-authored papers 12
Release 1.2